A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Bin Cao(Shandong Provincial Hospital), Chunmin Jia(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Ming Wei(Jinyintan Hospital), Ye Yuan(McGill University), Jie Xiang(Jinyintan Hospital), Sixia Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Huadong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaan Xia, Shunan Ruan(Chinese Academy of Medical Sciences & Peking Union Medical College), Kunxia Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuelei Xie, Peng Lü(Binzhou Medical University), Li-hong Pan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuan Dong(The Ohio State University), Shengjing Tu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiuyang Xu(Tsinghua University), Jun Zou(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Liu(Southwest Medical University), Hui Li(China-Japan Friendship Hospital), Xujuan Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Lianguo Ruan(Huazhong University of Science and Technology), Fang Cheng(Union Hospital), Xingwang Li(Henan Polytechnic University), Nanshan Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Guohui Fan(China-Japan Friendship Hospital), Fengyun Gong(Jinyintan Hospital), Wen Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuan Wei(James J. Peters VA Medical Center), Ke Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hua Chen, Yi Zhang(Tianjin Medical University General Hospital), Li Zhang(Huazhong University of Science and Technology), Caihong Li(Kobe Design University), Ting Yu(Chinese Academy of Sciences), Zhibo Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhaohui Qu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yeming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingli Wang(Wuhan University), Tao Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Wu(Xiamen University), Bin Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Xia Zhou(Shanxi Medical University), Han-Ping Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Danning Wen(Chinese Academy of Medical Sciences & Peking Union Medical College), Lianhan Shang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chongya Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanping Cai(Chinese Academy of Medical Sciences & Peking Union Medical College), Shanshan Luo(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 5,520
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k